Tolcapone

FDA Approved: * March 26, 2015
Pharm Company: * PAR PHARM INC
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Tolcapone Overview

Tolcapone (brand name Tasmar) is a drug used to treat Parkinson's disease (PD). It is a selective, potent and reversible nitrocatechol-type inhibitor of the enzyme catechol-O-methyltransferase (COMT).[1] It has demonstrated significant liver toxicity, which has led to suspension of marketing authorisations in a number of countries. In comparison with entacapone, another nitrocatechol COMT inhibitor, tolcapone has a longer half life (2.9 hours vs. 0.8 hours) and can better pen...

Read more Tolcapone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tolcapone

Recent Tolcapone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tolcapone
  • Tablet: 100mg, 200mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tolcapone: (3 results)

Sorted by National Drug Code
  • 49884-254 Tolcapone 100 1/1 Oral Tablet, Coated by Par Pharmaceutical Companies, Inc.
  • 50742-193 Tolcapone 100 mg Oral Tablet by Ingenus Pharmaceuticals, LLC
  • 68682-938 Tolcapone 100 mg Oral Tablet, Film Coated by Oceanside Pharmaceuticals

Other drugs which contain Tolcapone or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA